Abstract
Surgical patients are routinely prescribed opioid analgesics that are strongly associated with drug overdose deaths. Liposomal bupivacaine is a long-acting local anesthetic that received FDA approval in 2011 for local surgical site infiltration to promote post-operative analgesia. This anesthetic has demonstrated an improvement in post-operative pain control in various surgical realms, indicating a decreased need for opiates and subsequently decreased risks. However, few studies have investigated its use at the time of cesarean delivery.
Original language | American English |
---|---|
State | Published - Apr 30 2021 |
Event | 2021 Boonshoft School of Medicine Medical Student Research Symposium Abstracts and Posters - Virtual Duration: Apr 29 2021 → Apr 29 2021 |
Conference
Conference | 2021 Boonshoft School of Medicine Medical Student Research Symposium Abstracts and Posters |
---|---|
Period | 4/29/21 → 4/29/21 |
Disciplines
- Medical Education
- Obstetrics and Gynecology
- Surgery